Robert Andersen, MD
Family Medicine · Rockwall, TXNPI 1083647812
Payments from drug & device makers
Across 166 payments — averaging $15.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$452
- AstraZeneca$439
- GSK$253
- Pfizer$145
- Merck$144
- Amarin Pharma, Inc.$132
- plus $1K from 27 others
What the payments were for
- Food & beverage$2,653100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 30 | $452 |
| AstraZeneca | 28 | $439 |
| GSK | 15 | $253 |
| Pfizer | 10 | $145 |
| Merck | 13 | $144 |
| Amarin Pharma, Inc. | 7 | $132 |
| Lilly USA, LLC | 9 | $129 |
| Boehringer Ingelheim | 6 | $125 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $77 |
| Novartis | 4 | $77 |
| Upsher-smith Laboratories LLC | 4 | $73 |
| AbbVie | 3 | $61 |
| Amgen | 3 | $55 |
| Abbott | 3 | $55 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $47 |
| Exact Sciences | 2 | $45 |
| Esperion Therapeutics, Inc. | 2 | $42 |
| Astellas Pharma US Inc | 2 | $30 |
| Sanofi-aventis U.S. LLC | 2 | $27 |
| Sanofi Pasteur Inc. | 2 | $24 |
| Idorsia Pharmaceuticals US Inc | 1 | $20 |
| Genentech USA, Inc. | 1 | $20 |
| Nestle Healthcare Nutrition Inc. | 1 | $20 |
| Bristol Myers Squibb | 1 | $19 |
| Johnson & Johnson | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| Jazz Pharmaceuticals Inc. | 1 | $18 |
| Antares Pharma, Inc. | 1 | $17 |
| Alfasigma USA, Inc. | 1 | $15 |
| Collegium Pharmaceutical, Inc. | 1 | $15 |
| Shire North American Group Inc | 1 | $14 |
| Bayer | 1 | $14 |
| Adlon Therapeutics L.p. | 1 | $12 |
How this compares
$2,653 in reported general payments places this provider in the 75th percentile of 8,760 family medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 43 | $39,818 |
| JanuviaSitagliptin Phosphate | 32 | $31,306 |
| MounjaroTirzepatide | 27 | $31,023 |
| XareltoRivaroxaban | 17 | $23,959 |
| FarxigaDapagliflozin Propanediol | 22 | $22,050 |
| EliquisApixaban | 13 | $17,814 |
| JardianceEmpagliflozin | 13 | $16,908 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 11 | $4,733 |
| Levemir FlexpenInsulin Detemir | 11 | $3,528 |
| Atorvastatin Calcium | 309 | $2,710 |
| Rosuvastatin Calcium | 195 | $1,963 |
| Levothyroxine Sodium | 181 | $1,764 |
| Gabapentin | 88 | $1,760 |
| SynthroidLevothyroxine Sodium | 11 | $1,499 |
| Omeprazole | 67 | $1,405 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $452 | $39,81843 claims |
| MerckJanuvia | $144 | $31,30632 claims |
| Lilly USA, LLCMounjaro | $129 | $31,02327 claims |
| Johnson & JohnsonXarelto | $19 | $23,95917 claims |
| AstraZenecaFarxiga | $439 | $22,05022 claims |
| PfizerEliquis | $145 | $17,81413 claims |
| Boehringer IngelheimJardiance | $125 | $16,90813 claims |
| AbbVieSynthroid | $61 | $1,49911 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 8,760 family medicine providers in Texas.
Other family medicine in Rockwall
- Douglas DenhamSan Antonio$68.5M
- Vicki MillerPasadena$58.3M
- Hareshkumar BogharaDesoto$30.3M
- Earl MartinTomball$30.1M
- Lisa HollowayHouston$30.1M
- William SegerFort Worth$27.5M
- Veronica FragosoHouston$24.5M
- Joel SolisMcAllen$21.1M
- George AtieeSan Antonio$19.9M
- Bonnie ColvilleHouston$19.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.